Cited by 47Pluripotent Stem Cells ResearchNeurogenesis and neuroplasticity mechanisms3D Printing in Biomedical Research

Development and Characterization of Human Cerebral Organoids: An Optimized Protocol

Open access
Yakoub, Abraam M., Sadek, Mark·2018·Cell Transplantation

Abstract

Studies of human neurodevelopmental disorders and stem cell–based regenerative transplants have been hampered by the lack of a model of the developing human brain. Stem cell–derived neurons suffer major limitations, including the ability to recapitulate the 3-dimensional architecture of a brain tissue and the representation of multiple layers and cell types that contribute to the overall brain functions in vivo. Recently, cerebral organoid technology was introduced; however, such technology is still in its infancy, and its low reproducibility and limitations significantly reduce the reliability of such a model as it currently exists, especially considering the complexity of cerebral-organoid protocols. Here we have tested and compared multiple protocols and conditions for growth of organoids, and we describe an optimized methodology, and define the necessary and sufficient factors that support the development of optimal organoids. Our optimization criteria included organoids’ overall growth and size, stratification and representation of the various cell types, inter-batch variability, analysis of neuronal maturation, and even the cost of the procedure. Importantly, this protocol encompasses a plethora of technical tips that allow researchers to easily reproduce it and obtain reliable organoids with the least variability, and showcases a robust array of approaches to characterize successful organoids. This optimized protocol provides a reliable system for genetic or pharmacological (drug development) screens and may enhance understanding and therapy of human neurodevelopmental disorders, including harnessing the therapeutic potential of stem cell–derived transplants.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0963689717752946

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The success rate of on-chip tubular organoid formation is around 60%, comparable with the intrinsic success rate (70%) of the cerebral organoid protocol.

    “Overall, we observe a success rate of on-chip tubular organoid formation around 60%, a rate comparable with the intrinsic success rate (70%) with the cerebral organoid protocol.52”

    From Tubular human brain organoids to model microglia-mediated neuroinflammation (2021) · cites this paper as [52]

    The Procedures section describes measuring successful embryoid-body formation, and the Characterization section describes successful cerebral organoids, but neither passage gives a 70% success rate. Searches for “70% success rate” and cerebral-organoid formation efficiency found no passage establishing that figure. The on-chip 60% rate is presented as the citing authors’ own observation, not a result attributed to this source. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. [1]Kazdoba TM Leach PT Yang M Silverman JL Solomon M Crawley JN Translational mouse models of autism: advancing toward pharmacological therapeutics. Curr Top Behav Neurosci. 2016; 28: 1– 52. 27305922 PMC5116923
  2. [3]Nestor MW Phillips AW Artimovich E Nestor JE Hussman JP Blatt GJ Human inducible pluripotent stem cells and autism spectrum disorder: emerging technologies. Autism Res. 2016; 9(5): 513– 535. 26426199
  3. [5]Watanabe K Kamiya D Nishiyama A Katayama T Nozaki S Kawasaki H Watanabe Y Mizuseki K Sasai Y Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci. 2005; 8(3): 288– 296. 15696161
  4. [6]Eiraku M Sasai Y Self-formation of layered neural structures in three-dimensional culture of ES Cells. Curr Opin Neurobiol. 2012; 22(5): 768– 777. 22405989
  5. [7]Shi Y Kirwan P Smith J Robinson HP Livesey FJ Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci. 2012; 15(3): 477– 486. 22306606 PMC3882590
  6. [8]Mariani J Simonini MV Palejev D Tomasini L Coppola G Szekely AM Horvath TL Vaccarino FM Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012; 109(31): 12770– 12775. 22761314 PMC3411972
  7. [9]Sasai Y Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell. 2013; 12(5): 520– 530. 23642363
  8. [11]Mariani J Coppola G Zhang P Abyzov A Provini L Tomasini L Amenduni M Szekely A Palejev D Wilson M Gerstein M Grigorenko EL Chawarska K Pelphrey KA Howe JR Vaccarino FM FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell. 2015; 162(2): 375– 390. 26186191 PMC4519016
  9. [12]Lancaster MA Renner M Martin CA Wenzel D Bicknell LS Hurles ME Homfray T Penninger JM Jackson AP Knoblich JA Cerebral organoids model human brain development and microcephaly. Nature. 2013; 501(7467): 373– 379. 23995685 PMC3817409
  10. [14]Garcez PP Loiola EC Madeiro da Costa R Higa LM Trindade P Delvecchio R Nascimento JM Brindeiro R Tanuri A Rehen SK Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016; 352(6287): 816– 818. 27064148
  11. [15]Dang J Tiwari SK Lichinchi G Qin Y Patil VS Eroshkin AM Rana TM Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell. 2016; 19(2): 258– 265. 27162029 PMC5116380
  12. [16]Gabriel E Ramani A Karow U Gottardo M Natarajan K Gooi LM Goranci-Buzhala G Krut O Peters F Nikolic M Kuivanen S Korhonen E Smura T Vapalahti O Papantonis A Schmidt-Chanasit J Riparbelli M Callaini G Krönke M Utermöhlen O Gopalakrishnan J Recent Zika virus isolates induce premature differentiation of neural progenitors in human brain organoids. Cell Stem Cell. 2017; 20(3): 397– 406. 28132835
  13. [17]Lancaster MA Knoblich JA Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc. 2014; 9(10): 2329– 2340. 25188634 PMC4160653
  14. [18]Watanabe K Ueno M Kamiya D Nishiyama A Matsumura M Wataya T Takahashi JB Nishikawa S Nishikawa S Muguruma K Sasai Y A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007; 25(6): 681– 686. 17529971
  15. [20]Gaspard N Bouschet T Hourez R Dimidschstein J Naeije G van den Ameele J Espuny-Camacho I Herpoel A Passante L Schiffmann SN Gaillard A Vanderhaeghen P An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature. 2008; 455(7211): 351– 357. 18716623
  16. [22]Yi F Danko T Botelho SC Patzke C Pak C Wernig M Südhof TC Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science. 2016; 352(6286): aaf2669. PMC4901875 26966193
  17. [23]Menendez L Yatskievych TA Antin PB Dalton S Wnt signaling and a SMAD pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci U S A. 2011; 108(48): 19240– 19245. 22084120 PMC3228464
  18. [24]Kent L. Culture and maintenance of human embryonic stem cells. J Vis Exp. 2009; 34, pii:1427. PMC3152239 20029367
  19. [25]Kitsberg D Human embryonic stem cells for tissue engineering. Methods Mol Med. 2007; 140: 33– 65. 18085202

Cited by

Sorted by citations

Authors
Yakoub, A. M., & Sadek, M.
Affiliations
  • Stanford Medicine (US)
  • University of Illinois Chicago (US)
Corresponding author
Yakoub, Abraam M.
Venue
Cell Transplantation
Published
2018-03
Volume
27
Issue
3
Pages
393-406
ISSN
  • 0963-6897 (ISSN-L)
  • 1555-3892
OpenAlex
W2800784717
Cited by
47
References
6
Citations by year
2026: 1 · 2025: 7 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 9
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Cell Transplantation (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
brain organoids, human brain development, neurodevelopmental disorders, reproducibility, neuronal maturation, batch-to-batch variation, stem cell-derived neurons, drug screening model, organoid characterization
MeSH terms
Brain, Humans, Organoids, Stem Cells, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review